Risk Stratification by CMR After STEMI: Is it Time to Drop the Gadolinium?
- PMID: 35272809
- DOI: 10.1016/j.jcmg.2021.09.010
Risk Stratification by CMR After STEMI: Is it Time to Drop the Gadolinium?
Keywords: ST-segment elevation myocardial infarction; magnetic resonance imaging; risk stratification.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
A Noncontrast CMR Risk Score for Long-Term Risk Stratification in Reperfused ST-Segment Elevation Myocardial Infarction.JACC Cardiovasc Imaging. 2022 Mar;15(3):431-440. doi: 10.1016/j.jcmg.2021.08.006. Epub 2022 Jan 12. JACC Cardiovasc Imaging. 2022. PMID: 35272808 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
